Wolverine Trading, LLC Aveo Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$3.51 - $6.67 $62,126 - $118,059	-17,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.15 - $6.01 $55,755 - $106,377	17,700 New	17,700 $102,000
Q4 2021 Feb 14, 2022	SELL	$4.69 - $7.4 $148,204 - $233,840	-31,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.12 - $6.89 $161,792 - $217,724	31,600 New	31,600 $198,000
Q2 2021 Aug 06, 2021	SELL	$6.21 - $7.45 $232,875 - $279,375	-37,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.97 - $15.28 $94,923 - $242,952	-15,900 Reduced 29.78%	37,500 $260,000
Q4 2020 Feb 12, 2021	SELL	$5.08 - $6.68 $40,132 - $52,772	-7,900 Reduced 12.89%	53,400 $305,000
Q3 2020 Nov 13, 2020	BUY	$4.16 - $6.26 $9,568 - $14,398	2,300 Added 3.9%	61,300 $355,000
Q2 2020 Aug 13, 2020	BUY	$3.47 - $9.99 $54,132 - $155,844	15,600 Added 35.94%	59,000 $301,000
Q1 2020 May 11, 2020	BUY	$2.6 - $6.9 $112,840 - $299,460	43,400 New	43,400 $155,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.